August 3, 2021
PAR-21-280 - Dyadic interpersonal processes and biopsychosocial outcomes (R01, Basic Experimental Studies with Humans)
National Institute on Drug Abuse (NIDA)
This Notice informs potential applicants of NIDA-specific interest areas added to PAR-21-280, "Dyadic interpersonal processes and biopsychosocial outcomes (R01, Basic Experimental Studies with Humans)" effective immediately.
The following section of PAR-21-280 have been modified to reflect NIDA-Specific Interest Area language in this FOA:
Part 2. Full Text of Announcement
Section I. Funding Opportunity Description
National Institute on Drug Abuse (NIDA)
The National Institute on Drug Abuse (NIDA) supports research that furthers our mission to advance science on the causes and consequences of drug use and addiction, and to apply that knowledge to improve individual and public health. Areas of interest to NIDA under this FOA include, but are not limited to, the following:
All other aspects of the FOA remain unchanged.
Mary Kautz, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: (301) 443-3206
Email: kautzm@nida.nih.gov